2013, 6 April, A new publication on assay validation for integration in clinical trials

2013 - Lachno - JAD - SolanezumabThe founder was a co-author on a publication in Journal of Alzheimer’s disease entitled “Validation of assays for measurement of Amyloid-β peptides in cerebrospinal fluid and plasma specimens from patients with Alzheimer’s disease treated with Solanezumab.”

Read more . . .